Skip to content
lifestyle.smarttalksuccess.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Oculis Holding AG
Oculis Announces Completion of Last Patient Visit in Phase 3 DIAMOND Program with OCS-01 Eye Drops for the Treatment of Diabetic Macular Edema
May 4, 2026
Oculis to Participate in Upcoming Investor Conferences
May 3, 2026
Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First‑in‑Class Neuroprotective Candidate for Optic Neuritis
May 2, 2026
Oculis to Present at Upcoming North American Neuro-Ophthalmology Society Annual Meeting
April 29, 2026
Oculis to Participate in Upcoming Investor Conferences
April 28, 2026
Oculis Reports Q4 and Full Year 2025 Financial Results and Provides Company Update
April 28, 2026
Oculis Appoints Katie Kazem as Chief Legal Officer
February 17, 2026
←
Previous Page
1
2